Beacon Investment Advisory Services Inc. Has $284,000 Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Beacon Investment Advisory Services Inc. trimmed its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 8.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,150 shares of the financial services provider’s stock after selling 200 shares during the period. Beacon Investment Advisory Services Inc.’s holdings in iShares Biotechnology ETF were worth $284,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Darwin Wealth Management LLC acquired a new position in iShares Biotechnology ETF in the 3rd quarter valued at $29,000. Highline Wealth Partners LLC bought a new position in iShares Biotechnology ETF in the 3rd quarter valued at about $30,000. Ashton Thomas Securities LLC acquired a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at approximately $36,000. Modus Advisors LLC bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $41,000. Finally, Voisard Asset Management Group Inc. acquired a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $59,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $138.25 on Friday. The firm has a 50 day simple moving average of $135.97 and a two-hundred day simple moving average of $141.78. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.